does tirzepatide cause water retention Acid Reflux? FDA Data and Management Stopping Tirzepatide: What To Expect

In the SUSTAIN 6 CV outcomes trial (CVOT), once-weekly semaglutide (0.5 or 1.0 mg) added to standard of care significantly reduced the occurrence of a first major adverse CV event (MACE: CV death, nonfatal myocardial infarction [MI], or nonfatal stroke) vs placebo over 2 years in 3297 subjects with T2D and high CV risk [12]

But they work through different pathways, target different outcomes, and suit different patient profiles

What can we learn about the mechanism for the reduction of roGFP2(S 2 )

The lower dysesthesia rate in TRIUMPH-1 compared to TRIUMPH-4 at the same 12mg dose is noteworthy

12 weeks 3 vials Through 4 mg phase = 28 mg total

Semaglutide is approved for specific medical indications, including type 2 diabetes management and chronic weight management in eligible adults with obesity or overweight and certain weight-related health conditions